ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Cutting-edge product for stem cell research and human embryo modelling
Amsbio reports that its iMatrix-511 recombinant laminin product has been cited in a recent paper** from researchers at the Stanford University School of Medicine, Stanford, CA, USA as a pivotal tool for stem cell culture and blastoid formation.
Become a mentor on Beacon’s Patient Group Mentoring Programme and make a real difference to the rare disease community!
Mentees need support across a wide range of areas, from charity management and fundraising to communications, life sciences and more.
You don’t need a background in rare diseases to have something valuable to offer.
As a mentor, you will:
• Be paired with a rare disease patient group leader for a 12-month partnership
• Grow your leadership skills and aid your professional development
[Letchworth Garden City, December 2025] – DLRC Group has today announced its certification as a B Corporation (or B Corp), joining a growing movement of companies that are reinventing business for the benefit of all people and our shared planet. Verified by B Lab, the not-for-profit behind the B Corp movement, the achievement demonstrates that DLRC Group meets high standards of social and environmental performance, transparency, and accountability alongside a commitment to goals beyond shareholder value.
We are seeking an enthusiastic and talented Postdoctoral Research Scientist to join the David group at the Babraham Institute in Cambridge. Our overarching goal is to discover mechanisms that promote healthy ageing and alleviate age-related diseases such as Alzheimer’s disease. Our group has uncovered mechanisms that prevent age-related protein aggregation, a major contributor to functional decline. Notably, we discovered a proteostasis network that safeguards proteins from aggregation in the extracellular space in C.
Fisher Scientific's Research and Safety Division seeks an Account Manager to sell scientific products and services to UK Biotech customers.
Role
As a Lab Tech/Protein Scientist you will be a critical part of our technical bioprocessing team, helping to produce alternative milk proteins. You’ll support both upstream (cloning, strain selection) fermentation and downstream (protein extraction and purification) in a fast-paced, innovation-driven lab environment.
OutSee is a techbio startup that is defining the state of the art in genomic drug target discovery. Where current methods search for correlation between genetics and disease, our AI platform Nomaly searches for the causal biological mechanisms driving the disease.
So far, the techbio industry has its tunnel vision focused on the creation of binders. By applying our technology to target identification, we are transforming a fundamental but overlooked pillar of drug development.
BioFocus: Driving innovation, inspiring collaboration
BioFocus by Bionow is a dynamic one-day conference uniting leaders from industry, academia, and the wider life sciences community.
Designed to spark collaboration and accelerate innovation, BioFocus offers a powerful platform to connect, engage, and create new opportunities for growth. The event features an inspiring programme of keynote talks, expert panels, exhibition and dedicated networking sessions.
Innovating Healthcare Through Personalisation
Discover how precision medicine is transforming the healthcare landscape at the 2026 Bionow Precision Medicine Conference. This event brings together thought leaders, innovators, and healthcare professionals to explore advancements in personalised treatment approaches and their impact on patients.
The conference will showcase keynote speeches, engaging panel discussions, interactive exhibitions, and exceptional networking opportunities.
Why Attend?